Antioxidant dressing therapy versus standard wound care in chronic wounds (the REOX study): study protocol for a randomized controlled trial

Inés María Comino-Sanz, María Dolores López-Franco, Begoña Castro, Pedro Luis Pancorbo-Hidalgo, Inés María Comino-Sanz, María Dolores López-Franco, Begoña Castro, Pedro Luis Pancorbo-Hidalgo

Abstract

Background: A wound that does not heal in the orderly stages of the healing process or does not heal within 3 months is considered a chronic wound. Wound healing is impaired when the wound remains in the inflammatory stage for too long. A range of factors can delay the healing process: imbalance between proteases and protease inhibitors in the wound bed; bacterial colonization and the presence of biofilm; and oxidative stress. Recently, wound management has improved significantly. A new antioxidant dressing has been developed, which combines an absorbent matrix obtained from locust bean gum galactomannan and a hydration solution with curcumin and N-acetylcysteine. This dressing combines the advantages of moist healing in exudate management and free radical neutralization, achieving wound reactivation. The primary aim of this study is to compare the effect of the antioxidant dressing on chronic wound healing against the use of a standard wound dressing in patients with hard-to-heal wounds.

Methods: We will conduct a multicentre, single-blind, randomized controlled trial with parallel groups. Participants will be selected from three primary public health care centres located in Andalucía (southern Spain). Patients will be randomized into an intervention group (antioxidant dressing) or a control group (standard wound dressing). Assessments will be carried out at weeks 2, 4, 6 and 8. Follow-up will be for a period of 8 weeks or until complete healing if this occurs earlier.

Discussion: The findings from this study should provide scientific evidence on the efficacy of the antioxidant dressing as an alternative for the treatment of chronic wounds. This study fills some of the gaps in the existing knowledge about patients with hard-to-heal wounds.

Trial registration: ClinicalTrials.gov: NCT03934671. Registered on 2 May 2019.

Keywords: Antioxidant dressing; Chronic wound; Hard-to-heal wounds; Oxidative stress; Wound healing.

Conflict of interest statement

BC is an employee of Histocell (the collaborating company). The other authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Standard Protocol Items: Recommendations for Interventional Trials (adapted from SPIRIT figure) schedule of enrolment, interventions and assessments. MUST malnutrition universal screening tool, VAS visual analogue scale
Fig. 2
Fig. 2
Schedule of enrolment

References

    1. Guo S, Di Pietro LA. Factors affecting wound healing. J Dent Res. 2010;89(3):219–229.
    1. Atkin L, Bućko Z, Conde Montero E, Cutting K, Moffatt C, Probst A, Romanelli M, Schultz GS, Tettelbach W. Implementing TIMERS: the race against hard-to-heal wounds. J Wound Care. 2019;28(3 Suppl 3):S1–S49.
    1. Diegelmann RF, Evans MC. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci. 2004;9:283–289.
    1. Drew P, Posnett J, Rusling L. The cost of wound care for a local population in England. Int Wound J. 2007;4(2):149–155.
    1. Hopman WM, Buchanan M, Vandenkerkhof EG, Harrison MB. Pain and health-related quality of life in people with chronic leg ulcers. Chronic Dis Inj Can. 2013;33(3):167–174.
    1. McCarty SM, Percival SL. Proteases and delayed wound healing. Adv Wound Care. 2013;2(8):438–447.
    1. Schultz GS, Wysocki A. Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen. 2009;17(2):153–162.
    1. Sabino F, Keller U. Matrix metalloproteinases in impaired wound healing. Metalloproteinases Med. 2015;2:1–8.
    1. James GA, Swogger E, Wolcott R, et al. Biofilms in chronic wounds. Wound Repair Regen. 2008;16(1):37–44.
    1. Metcalf DG, Bowler PG. Biofilm delays wound healing: a review of the evidence. Burns Trauma. 2013;1(1):5–12.
    1. Mendoza RA, Hsieh J, Galiano RD. The impact of biofilm formation on wound healing. In: Wound healing - current perspectives; 2019. 10.5772/intechopen.85020. .
    1. Schaffer SW, Jong CJ, Mozaffari M. Role of oxidative stress in diabetes-mediated vascular dysfunction: unifying hypothesis of diabetes revisited. Vasc Pharmacol. 2012;57(5–6):139–149.
    1. Attinger C, Wolcott R. Clinically addressing biofilm in chronic wounds. Adv Wound Care. 2012;1(3):127–132.
    1. Menke NB, Ward KR, Witten TM, et al. Impaired wound healing. Clin Dermatol. 2007;25:19–25.
    1. Vermeij WP, Backendorf C. Skin cornification proteins provide global link between ROS detoxification and cell migration during wound healing. PLoS One. 2010;5(8):e11957.
    1. Wagener F, Carels C, Lundvig D. Targeting the redox balance in inflammatory skin conditions. Int J Mol Sci. 2013;14(5):9126–9167.
    1. Roy S, Khanna S, Nallu K, et al. Dermal wound healing is subject to redox control. Mol Ther. 2006;13(1):211–220.
    1. Fitzmaurice SD, Sivamani RK, Isseroff RR. Antioxidant therapies for wound healing: a clinical guide to currently commercially available products. Skin Pharmacol Physiol. 2011;24(3):113–126.
    1. Sen CK. The general case for redox control of wound repair. Wound Repair Regen. 2003;11(6):431–438.
    1. Singh O, Gupta SS, Soni M, Moses S, Shukla S, Mathur RK. Collagen dressing versus conventional dressings in burn and chronic wounds: a retrospective study. J Cutan Aesthet Surg. 2011;4(1):12–16.
    1. Shekhter AB, Fayzullin AL, Vukolova MN, Rudenko TG, Osipycheva VD, Litvitsky PF. Medical applications of collagen and collagen-based materials. Curr Med Chem. 2019;26(3):506–516.
    1. Krejner A, Grzela T. Modulation of matrix metalloproteinases MMP-2 and MMP-9 activity by hydrofiber-foam hybrid dressing—relevant support in the treatment of chronic wounds. Cent Eur J Immunol. 2015;40(3):391–394.
    1. Klebanov GI, Liubitskiĭ OB, Il'ina SE, Medusheva EO, Ryl'tsev VV, Filatov VN. Antioxidant activity of inhibitors of free radical reactions in the dressing materials for wound healing. Biomed Khim. 2006;1:69–82.
    1. Castro B, Palomares T, Azcoitia I, et al. Development and preclinical evaluation of a new galactomannan-based dressing with antioxidant properties for wound healing. Histol Histopathol. 2015;30(12):1499–1512.
    1. Petkova N, Petrova I, Ivanov I, Mihov R, Hadjikinova R, Ognyanov M, Nikolova V. Nutritional and antioxidant potential of carob (Ceratonia siliqua) flour and evaluation of functional properties of its polysaccharide fraction. J Pharm Sci Res. 2017;9(11):2189–2195.
    1. Hu P, Huang P, Chen MW. Curcumin reduces Streptococcus mutans biofilm formation by inhibiting sortase A activity. Arch Oral Biol. 2013;58(10):1343–1348.
    1. Packiavathy IA, Priya S, Pandian SK, Ravi AV. Inhibition of biofilm development of uropathogens by curcumin—an anti-quorum sensing agent from Curcuma longa. Food Chem. 2014;148:453–460.
    1. Ozkaya H, Bahat G, Tufan A, et al. Successful treatment of non-healing pressure ulcers with topical N-acetyl cysteine. J Wound Care. 2015;24(12):606–611.
    1. Zhao T, Liu Y. N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa. BMC Microbiol. 2010;10(1):140.
    1. Gupta SC, Patchva S, Koh W, Aggarwal BB. Discovery of curcumin, a component of golden spice, and its miraculous biological activities. Clin Exp Pharmacol Physiol. 2012;39(3):283–299.
    1. Scharstuhl A, Mutsaers HA, Pennings SW, et al. Curcumin-induced fibroblast apoptosis and in vitro wound contraction are regulated by antioxidants and heme oxygenase: implications for scar formation. J Cell Mol Med. 2009;13(4):712–725.
    1. Jagetia GC, Rajanikant GK. Effect of curcumin on radiation-impaired healing of excisional wounds in mice. J Wound Care. 2004;13(3):107–109.
    1. Deniz M, Borman H, Seyhan T, Haberal M. An effective antioxidant drug on prevention of the necrosis of zone of stasis: N-acetylcysteine. Burns. 2013;39(2):320–325.
    1. Kheradpezhouh E, Panjehshahin MR, Miri R, Javidnia K, Noorafshan A, Monabati A, et al. Curcumin protects rats against acetaminophen-induced hepatorenal damages and shows synergistic activity with N-acetyl cysteine. Eur J Pharmacol. 2010;628(1–3):274–281.
    1. Castro B, Bastida FD, Segovia T, López Casanova P, Soldevilla JJ, Verdú-Soriano J. The use of an antioxidant dressing on hard to heal wounds: a multicentre, prospective case series. J Wound Care. 2017;26(12):742–775.
    1. Jiménez García JF, Abad García MM, Ortiz Villegas L, Zarco Marín JM, Expósito Torres R, García Fernández FP. Cicatrización de úlceras venosas complejas mediante el control del estrés oxidativo. Rev ROL Enferm. 2018;41(11–12):739–744.
    1. Restrepo-Medrano JC, Verdú Soriano J. Development of a wound healing index for chronic wounds. EWMA J. 2012;12(2):39–46.
    1. Lee M, Han SH, Choi WJ, Chung KH, Lee JW. Hyaluronic acid dressing (Healoderm) in the treatment of diabetic foot ulcer: a prospective, randomized, placebo-controlled, single-center study. Wound Repair Regen. 2016;24(3):581–588.
    1. Kundin J. A new way to size up a wound. Am J Nurs. 1989;89(2):206–207.
    1. Verdú Soriano J, López Casanova P, Rodríguez Palma M, García Fernández FP, Pancorbo Hidalgo PL, Soldevilla Ágreda JJ. HELCOS. Sistema integrado para el manejo de heridas. Rev ROL Enferm. 2018;41(11–12):778–783.
    1. HELCOS . Integrated wound management system. 2017.
    1. Mao G, Goswami M, Kalen AL, Goswami PC, Sarsour EH. N-acetyl-L-cysteine increases MnSOD activity and enhances the recruitment of quiescent human fibroblasts to the proliferation cycle during wound healing. Mol Biol Rep. 2016;43(1):31–39.
    1. Bell ML, Fiero M, Horton NJ, Hsu CH. Handling missing data in RCTs; a review of the top medical journals. BMC Med Res Methodol. 2014;14:118.
    1. Sussman C, Bates-Jensen BM. Skin and soft tissue anatomy and wound healing physiology. In: Sussman C, Bates-Jensen BM, editors. Wound care. A collaborative practice manual for health professionals. Beijing: Wolters Kluwer; 2012. pp. 17–52.

Source: PubMed

3
Se inscrever